Stocks & Equities

Dow 36,000 … (correction 16,000)

McIver Wealth Management Consulting Group / Richardson GMP Limited
Five Year Chart of the Dow Industrials

The Dow reached 16,000 for the first time this morning.

That got me thinking about the book titled Dow 36,000: The New Strategy for Profiting from the Coming Rise in the Stock Market which was published in the year 2000. 13 years later and only 20,000 points short!

The news of “Dow 16,000” appears to be celebrated a little more than previous milestones since it coincides with the S&P 500 hitting 1,800 for the first time on the same morning.

With all the celebrating and headline frenzy, there has not been much chatter all with respect to what has driven the Dow to this new high. Almost all of the gains over the past two years have been the result of easy monetary policy. Corporate non-financial earnings have essentially been flat over this time, and financial earnings have been largely subsidized by the U.S. Federal Reserve paying interest (which it never did until a couple of years ago) on the $3 trillion of commercial bank excess reserves held on deposit at the Fed.

“Dow 16,000” should serve as a reminder to us to ask when earnings growth is coming. Will an economy that is more sluggish that the Fed and private economists expected be able to produce more earnings? Can companies cut even more costs (and employees) to squeeze out more earnings in order to justify their share prices?

At “Dow 16,000” these questions carry more weight than at “Dow 15,000” and “Dow 14,000” etc. If earnings don’t materialize, then maybe more Quantitative Easing will be required. Bulls might be happy to know that the next Fed Chairman Janet Yellen won’t have many qualms about doing this regardless of the long-term costs and ramifications.

The opinions expressed in this report are the opinions of the author and readers should not assume they reflect the opinions or recommendations of Richardson GMP Limited or its affiliates. Assumptions, opinions and estimates constitute the author’s judgment as of the date of this material and are subject to change without notice. We do not warrant the completeness or accuracy of this material, and it should not be relied upon as such. Before acting on any recommendation, you should consider whether it is suitable for your particular circumstances and, if necessary, seek professional advice. Past performance is not indicative of future results. 

Richardson GMP Limited, Member Canadian Investor Protection Fund.

Richardson is a trade-mark of James Richardson & Sons, Limited. GMP is a registered trade-mark of GMP Securities L.P. Both used under license by Richardson GMP Limited.

Despite efforts by India’s government to curb demand for precious metals, consumers have been rather resilient as gold has strong culture significance in India. 

From the government perspective, investment in gold is crowding out funds that’s would go into a struggling banking sector and support the overall the economy. That is often why gold is referred to as a “dead asset” as the capital is unproductive from an economic stand point. 

That being said, the Indian Rupee is down over 15 percent this year against the US dollar, and despite the metals fall, in the Indian culture it continues to be a store of value and a sign of wealth. 

Click here to report.

Robert Levy

Border Gold Corp.

rlevy@bordergold.com | 1.888.312.2288

www.bordergold.com

 

Vaults are Booming!

UnknownSwitzerland has been a sanctuary for high-net-worth capital for the better part of the last century. Today, however, the rich are choosing a different destination to stash their wealth – Asia. Gold, silver and collectibles are pouring into Singapore, Hong Kong and Shanghai, jurisdictions that now offer some of the most exclusive gold and silver vault options in the world.

…read it all HERE

Yellen Commits – Stocks Surge

Screen Shot 2013-11-17 at 1.01.38 PMLance’s thorough Stock Market Analysis – Ed

To start this week’s missive I want to share with you an excerpt from Randall Forsythe’s “Up and Down Wallstreet” column this weekend:

“IN A NEW STUDY, McKinsey & Co. concluded the Fed had no role in boosting stock prices and hence there is no bubble. Truth to tell, the consultancy had slipped from my consciousness since it extolled Enron as “one of the world’s most innovative companies,” instead of a criminal enterprise. Of course, since then, former McKinsey managing director Rajat Gupta was convicted of insider trading.  McKinsey advised AT&T there wasn’t much future in mobile phones (which Bell Labs invented); advised General Electric, which lost $1 billion by following its advice; recommended that U.K. rail company Railtrack cut infrastructure spending, leading to fatal accidents and Railtrack’s collapse, among other great calls.

In particular, McKinsey asserts there has not been a large-scale shift to equities in search of higher returns. To be fair, the consultancy’s paper preceded the report from colleague Brendan Conway on Barrons.comthat inflows into equity mutual funds and exchange-traded funds are on track to top $450 billion in 2013 — more than the previous four years combined. Anybody can overlook nearly a half-trillion bucks in concluding there’s been no big shift to stocks.

McKinsey based its conclusions on the observation that price/earnings ratios and price-to-book ratios aren’t out of line. Yellen pointed out the equity-risk premium — the expected extra return from stocks over risk-free government bonds — adequately compensates investors. On the latter score, the equity-risk premium is flattered by the low level of Treasury yields — QE’s explicit goal. As for P/Es being moderate, that’s helped by the numerator being boosted by the reduction of interest expense — some $319 billion since 2007, according to ever-invaluable analysis from MacroMavens’ Stephanie Pomboy.

Even with this detachment from reality, and fundamentals, the markets advanced higher this week as Janet Yellen promised MORE, and potentially MUCH MORE, accommodative policy in the future.

Not coincidentally, the Wall Street Journal reports investment-grade corporate-bond issuance is running at a $1 trillion annual rate as companies take advantage of historically low rates, with which the Fed has had something to do. Moreover, the release of banks’ loan-loss reserves has added $112 billion to financial companies’ profits in the past two years, Pomboy says, which just might have something to do with higher house prices. 

At the same time, an analysis by a famous hedge fund (whose name I can’t reveal or they’d kill me or I’d have to kill you) finds profits at non financial companies have been flat since 2011. Thus, the rise in their stock prices implies higher P/Es — consistent with the effects of monetary stimulation.

The assertion the Fed has had nothing to do with the stock-market rise is all the more curious, given that was the central bank’s explicit goal. Bernanke wrote in the Washington Post in November 2010, on the occasion of the second round of QE, that ‘higher equity prices will boost consumer wealth and help increase confidence, which can spur spending.’ On that score, Pomboy points to the divergence between stocks and spending, with the latter lagging the averages. 
 
The stock market is benefitting from excellent PR, better than the fundamentals.” 
 
That excellent analysis of the fundamentals in one thing, however, all Mackenzie had to do was simply look at the highly correlated relationship between the size of the Fed’s balance sheet and the stock market.
 
Screen Shot 2013-11-17 at 12.52.24 PM

 

 

 

 

 

 

 

 

 

 

 

 

 

 

What is probably most disturbing though is that Janet Yellen does NOT

BELIEVE, despite mounting evidence to the contrary, that investment risk is

rising:

  • Yellen Says Fed Doesn’t See Buildup Of Financial Risks
  • Yellen Sees Limited Evidence Of ‘Reach For Yield’
  • Yellen Says Fed Looks Out For Any Potential Asset Price Bubbles
  • Yellen Doesn’t See `Misalignments’ In Asset Prices

….read more HERE

3D Revolution: The Future Is Now, Cash In

Screen Shot 2013-11-17 at 7.03.53 AM“Human tissues, metal guns, prosthetic limbs, tools, household articles, clothes, among thousands of other products. The major players include 3D Systems , voxeljet AG (VJET), Stratasys (SSYS), ExOne (XONE), ARCAM AB (OTC:AMAVF) and Organovo Holdings (ONVO), with Hewlett Packard (HPQ) and 3M (MMM) also preparing to enter the market.”

3D Revolution: The Future Is Now, Cash In

There was a time when every Star-Trek fan pined for the on-ship replicators that had the capability to produce anything ranging from food to hardware, and today we are close to that fantasy turning to a reality in the form of 3D Printing. This industry, touted as the next big revolution, has piqued the interest of technology lovers and investors alike. It has been heavily discussed in blogs, news and the like for its ability to grow and sustain the promise it has. There are those who believe that this is the future. On the contrary, there are those who believe that this is all a hype and gimmick and will die down as fast as it spread. I, for one, don’t believe that this is just hype; there is indeed a bright future in the industry, and it is already proving that by integrating itself into mainstream manufacturing.

The Industry

3D printing uses a 3D printer and digital technology to print anything digitally modeled. The process also known as additive manufacturing uses successive layering of materials to form any shape wanted. The first working printer was created in 1984 by the founder of 3D Systems Corporation (DDD), Chuck Hull. However, the sales of these printers have picked up heavily in the 21st century and have become more widespread. The materials used in printing include polymers, powders, metals and alloys, resins, ceramics, sand, living tissues, and others. Metal-based printing has the potential to revolutionize the market.

The industry consists of many private and publicly traded companies investing their efforts in taking this revolution to the next step. Some of the major players include 3D Systems , voxeljet AG (VJET), Stratasys (SSYS), ExOne (XONE), ARCAM AB (OTC:AMAVF) and Organovo Holdings (ONVO), with Hewlett Packard (HPQ) and 3M (MMM) also preparing to enter the market.

The 3D printers presently are highly priced, owing to the patents preventing competition in the industry. These patents related to laser sintering expire in February 2014, which will open the avenue for manufacturing low-priced 3D printers. This expiration is being viewed as a major game-changer in the 3D printing industry.

According to Wohler’s Report 2013, the worldwide market of 3D printing and services expanded from $1.3 billion in 2010 to $2.2 billion in 2012. The industry average annual growth [CAGR] over the past 25 years is a striking 25.4%, with a 27.4 percent for the years 2010 through 2012. Additionally, the low cost personal 3D printers market averaged almost 346%, from 2008 to 2011. The main buyers included do-it-yourselfers, engineering students, hobbyists, and educational institutions.

Application

3D printing has found its application in aerospace, automotive, healthcare, biotechnology, fashion, education, media, engineering, industrial design, defense, consumer, and defense among other uses. Products that have been manufactured or produced using 3D printing include human tissues, metal guns, prosthetic limbs, tools, household articles, clothes, among thousands of other products.

In the aerospace area, NASA plans to launch a 3D printer into space next year, which will allow the astronauts to print the tools instead of carrying the load from here. Rolls Royce also plans to manufacture parts of its engines using 3D printing, as it is much faster and easier to use. Similarly, GE Aviation also plans to use 3D printing for its jet engines.

Other major companies that have turned towards 3D printing include Audi, Siemens (SI), BMW, Staples (SPLS), UPS (UPS), Microsoft Stores (MSFT), ASDA, Victoria’s Secret, L’Oreal and Porsche, to name a few.

Major Players

Organovo Holdings is a biotechnology company focusing on 3D bioprinting technology to create functional human tissues for medical and research applications. The products of the company aim at reducing the expenditure on clinical trials for drug testing. It will be launching its 3D human tissue liver for toxicity testing next year. The company has the right collaborations, and at the moment, has no major competitor. The share price, as on November 14, was $11.90, with a market capitalization of $919.61 million.

voxeljet AG , a German company, provides 3D printers and on-demand parts services, in the areas of automotive, aerospace, engineering, architecture, science and medical, film and entertainment and art. The company went public last month, with an opening price of $20 and is now trading at $52.40, as of November 14, 2013. The company turned to profitability with the recent earnings announcement for the third quarter and reported an increase in its product sales, with a market capitalization of $817.44 million, as of November 14. The company has celebrated customers that include Ford (F), BMW, Porsche, 3M, Daimler, among others. They also created the Aston Martin DB5 plastic double for the James Bond movie Skyfall.

3D Systems, a 3D printing giant, develops, produces and markets 3D printers, materials, customer services and authoring solutions for consumers and professionals. It operates primarily in the automotive, computer, electronic, aerospace, energy, consumer, education, defense, and healthcare products. The company primarily operates in the U.S., Europe, and Asia Pacific. The company has a trading price of $78.90 as of November 14 with a market capitalization of $8.1 billion.

Stratasys Inc. is a worldwide leader in the manufacturing of 3D printers and high performance rapid prototyping [RP] systems for direct digital manufacturing [DDM] and office-based RP systems. It offers solutions in the apparel, aerospace, automotive, architecture, business machine products, dental, defense, electronics, consumer, educational institutions, jewelry, heavy equipment, toys and medical industries. The company is trading at $124.10 as on November 14, with a market capitalization of $6.04 billion.

Future

3D printing is without a doubt an exponentially lucrative industry and is sure to fill many pockets as it keeps growing. The stock prices of the companies in 3D printing have seen a sharp up rise with substantial gains. It is not only an attractive technology, but also has the potential to cut the costs that go into research and development, manufacturing, extensive labor-force and the like. It allows for customized products for every customer, targeting market niches without incurring major costs.

The 3D printing industry has further been supported by President Obama, as he mentioned in his State of Union Address at the start of the year, that the industry has the potential to revolutionize manufacturing. The industry is no doubt in its infancy, but has garnered a lot of attention, with increased investments and research, which could only help in accelerating the progress. And with the giants such as HP and 3M entering the market, it is heavily anticipated to grow and fast. Additionally, the expiration of patents relating to printing technology will not only witness a surge of printers, but also increased competition.

According to MarketsandMarket research, the 3D printing market from 2013-2020 is expected to grow at CAGR of 23% and reach $8.41 billion. My take on the stocks of the 3D printing companies is that they should be bought in truckloads, as when the industry takes off as expected, there would be a surge in the stock prices, and a gradual rise can already be seen. Of course, the financial conditions and products of the companies must be analyzed before investing. The best options are Organovo, Stratasys, voxeljet, and 3D Systems.